Spectranetics Corp  

(Public, NASDAQ:SPNC)   Watch this stock  
Find more results for The Spectranetics Corp
21.47
+0.04 (0.19%)
After Hours: 21.47 0.00 (0.00%)
Jul 28, 4:55PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 21.05 - 21.92
52 week 10.65 - 22.08
Open 21.38
Vol / Avg. 568,064.00/463,421.00
Mkt cap 897.36M
P/E     -
Div/yield     -
EPS -1.17
Shares 42.81M
Beta 1.15
Inst. own 106%
Jul 28, 2016
Q2 2016 Spectranetics Corp Earnings Call - Webcast
Jul 28, 2016
Q2 2016 Spectranetics Corp Earnings Release
May 25, 2016
Spectranetics Corp at UBS Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -27.50% -24.18%
Operating margin -22.13% -31.04%
EBITD margin - -7.23%
Return on average assets -15.10% -12.72%
Return on average equity -62.50% -42.61%
Employees 892 -
CDP Score - -

Address

9965 Federal Dr
COLORADO SPRINGS, CO 80921-3822
United States - Map
+1-719-6338333 (Phone)
+1-877-4472022 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company's products are used to cross, prepare and treat arterial blockages in the heart and legs and to manage pacemaker and defibrillator cardiac leads. Its geographic segments are U.S. Medical and International Medical. Its product offerings in U.S. Medical segment include medical devices used in minimally invasive procedures within the cardiovascular system, including fiber-optic devices and non-fiber-optic products (disposables), an excimer laser system (equipment) and the service of the excimer laser system (service). Its products are used in multiple vascular procedures, including peripheral atherectomy, crossing arterial blockages, coronary atherectomy and thrombectomy. Its International Medical segment is primarily engaged in distribution activities.

Officers and directors

R. John Fletcher Independent Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
Scott William Drake President, Chief Executive Officer, Director
Age: 47
Bio & Compensation  - Reuters
Stacy McMahan Chief Financial Officer
Age: 51
Bio & Compensation  - Reuters
Shahriar Matin Chief Operating Officer
Age: 40
Bio & Compensation  - Reuters
Paul Gardon Senior Vice President, General Counsel
Age: 49
Bio & Compensation  - Reuters
Donna Ford-Serbu Senior Vice President - Sales and Marketing of Lead Management
Age: 46
Bio & Compensation  - Reuters
Robert Michael Fuchs Senior Vice President, Global Head - Human Resources
Age: 48
Bio & Compensation  - Reuters
Udo Scheiner Senior Vice President - International Operations
Bio & Compensation  - Reuters
Austin B. Byrd Chief Compliance Officer, Vice President
Age: 49
Bio & Compensation  - Reuters
Wade A. Bowe Vice President - Research & Development
Age: 44
Bio & Compensation  - Reuters